Literature DB >> 20941601

Methods for in vitro generation of human type 1 regulatory T cells.

Silvia Gregori1, Maria Grazia Roncarolo, Rosa Bacchetta.   

Abstract

Type 1 regulatory T (Tr1) cells are adaptive regulatory T cells that are induced in the periphery upon chronic exposure to antigen (Ag) in a tolerogenic environment containing interleukin (IL)-10. Tr1 cells are Ag-specific; they produce high levels of IL-10 and TGF-β in the absence of IL-4 and suppress T-cell responses via a cytokine-dependent mechanism. During the last decade, several protocols have been developed to generate Tr1 cell lines in vitro. In this chapter, we outline protocols to generate non-Ag- and Ag-specific Tr1 cell lines and assays used to characterize Tr1 cell phenotype and functions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20941601     DOI: 10.1007/978-1-60761-869-0_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  14 in total

Review 1.  Ulcerative colitis: immune function, tissue fibrosis and current therapeutic considerations.

Authors:  Jochen Maul; Martin Zeitz
Journal:  Langenbecks Arch Surg       Date:  2011-04-09       Impact factor: 3.445

2.  Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells.

Authors:  Nicola Gagliani; Chiara F Magnani; Samuel Huber; Monica E Gianolini; Mauro Pala; Paula Licona-Limon; Binggege Guo; De'Broski R Herbert; Alessandro Bulfone; Filippo Trentini; Clelia Di Serio; Rosa Bacchetta; Marco Andreani; Leonie Brockmann; Silvia Gregori; Richard A Flavell; Maria-Grazia Roncarolo
Journal:  Nat Med       Date:  2013-04-28       Impact factor: 53.440

Review 3.  Aryl hydrocarbon receptor control of adaptive immunity.

Authors:  Francisco J Quintana; David H Sherr
Journal:  Pharmacol Rev       Date:  2013-08-01       Impact factor: 25.468

4.  New tools to expand regulatory T cells from HIV-1-infected individuals.

Authors:  Mathieu Angin; Melanie King; Marylyn Martina Addo
Journal:  J Vis Exp       Date:  2013-05-30       Impact factor: 1.355

Review 5.  Next-generation regulatory T cell therapy.

Authors:  Leonardo M R Ferreira; Yannick D Muller; Jeffrey A Bluestone; Qizhi Tang
Journal:  Nat Rev Drug Discov       Date:  2019-09-20       Impact factor: 84.694

Review 6.  Regulatory T cells and natural killer T cells for modulation of GVHD following allogeneic hematopoietic cell transplantation.

Authors:  Dominik Schneidawind; Antonio Pierini; Robert S Negrin
Journal:  Blood       Date:  2013-09-25       Impact factor: 22.113

7.  HLA-G expression levels influence the tolerogenic activity of human DC-10.

Authors:  Giada Amodio; Michela Comi; Daniela Tomasoni; Monica Emma Gianolini; Roberta Rizzo; Joël LeMaoult; Maria-Grazia Roncarolo; Silvia Gregori
Journal:  Haematologica       Date:  2015-02-06       Impact factor: 9.941

8.  Human tolerogenic DC-10: perspectives for clinical applications.

Authors:  Giada Amodio; Silvia Gregori
Journal:  Transplant Res       Date:  2012-09-28

9.  Immunological Outcome in Haploidentical-HSC Transplanted Patients Treated with IL-10-Anergized Donor T Cells.

Authors:  Rosa Bacchetta; Barbarella Lucarelli; Claudia Sartirana; Silvia Gregori; Maria T Lupo Stanghellini; Patrick Miqueu; Stefan Tomiuk; Maria Hernandez-Fuentes; Monica E Gianolini; Raffaella Greco; Massimo Bernardi; Elisabetta Zappone; Silvano Rossini; Uwe Janssen; Alessandro Ambrosi; Monica Salomoni; Jacopo Peccatori; Fabio Ciceri; Maria-Grazia Roncarolo
Journal:  Front Immunol       Date:  2014-01-31       Impact factor: 7.561

10.  Standardization of whole blood immune phenotype monitoring for clinical trials: panels and methods from the ONE study.

Authors:  Mathias Streitz; Tewfik Miloud; Michael Kapinsky; Michael R Reed; Robert Magari; Edward K Geissler; James A Hutchinson; Katrin Vogt; Stephan Schlickeiser; Anders Handrup Kverneland; Christian Meisel; Hans-Dieter Volk; Birgit Sawitzki
Journal:  Transplant Res       Date:  2013-10-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.